Skip to content
TrialScanner

NCT02245516

Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema

No phase registeredCompletedKALALead

Registry record

Lead sponsor
Kala Pharmaceuticals, Inc.
Conditions
Retinal Vein Occlusion; Diabetic Macular Edema
Primary completion
Dec 2014Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02245516 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02245516: Exploratory Study of KPI-121... | TrialScanner